Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

Genmab enters into research collaboration with Lilly for DuoBody technology platform Danish biotechnology firm Genmab has entered into a research collaboration with Eli Lilly and Company to use and assess Genmab's DuoBody technology platform to develop bispecific antibodies. Contract Research & Services > Contract Research > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

Kyowa Hakko begins Phase III trial of asthma drug benralizumab in Japan
17 April 2014 | By PBR Staff Writer
Japan-based Kyowa Hakko Kirin has started a Calima, one of several trials in the Phase III program for benralizumab, and also plans to initiate Sirocco, another Phase III trial in South Korea.
Contract Research & Services > Clinical Trials > News
Akebia Therapeutics completes enrollment in its Phase IIb clinical study of AKB-6548
16 April 2014
Akebia Therapeutics, a biopharmaceutical company, has completed enrollment in its ongoing 200-patient Phase IIb study of AKB-6548 for the treatment of anemia associated with chronic kidney disease (CKD) in patients who are not dependent on dialysis.
Contract Research & Services > Clinical Trials > News

Contract Research

IntelliCell BioSciences selects inVentiv Health Clinical as CRO for osteoarthritis IND
15 April 2014
inVentiv Health Clinical has been selected by IntelliCell BioSciences, a regenerative medicine company, as contract research organization (CRO) for conducting a clinical trial in osteoarthritis of the knee under an Investigational New Drug (IND) application.
Contract Research & Services > Contract Research > News
ProTrials completes significant Phase III clinical trial for new ophthalmic disease treatment
15 April 2014
ProTrials Research has announced the completion of a large Phase III clinical study examining the safety and effectiveness of a new treatment for dry eye disease.
Contract Research & Services > Contract Research > News

Contract Services

AMRI realigns discovery and development services to support customer demand
17 April 2014
Albany Molecular Research (AMRI) has announced that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, New York site to other sites within AMRI and will cease operations in Syracuse by the end of June 2014.
Contract Research & Services > Contract Services > News
Prosonix, Mylan license agreement for generic versions of Flixotide and Flovent
16 April 2014 | By PBR Staff Writer
Prosonix, a UK-based speciality pharmaceutical firm developing a portfolio of inhaled Respiratory Medicines by Design, has entered into a global licensing agreement with Mylan, for its inhaled respiratory products, PSX1001 and PSX1050, which emerged from Prosonix's particle engineering platform.
Contract Research & Services > Contract Services > News